Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2010 | 04-2010 | 01-2010 | 10-2009 | 07-2009 | |
| Sales | 58 | 323 | 39 | 119 | 300 |
| Cost of Goods | 34 | 19 | 22 | 7 | 35 |
| Gross Profit | 24 | 304 | 17 | 112 | 265 |
| Operating Expenses | 1,328 | 1,663 | 1,550 | 3,489 | 1,490 |
| Operating Income | -1,270 | -1,340 | -1,511 | -3,370 | -1,190 |
| Other Income | 0 | 69 | 4 | -9,215 | 5 |
| Pre-tax Income | -1,270 | -1,272 | -1,506 | -12,584 | -1,186 |
| Net Income Continuous | -1,270 | -1,272 | -1,506 | -12,584 | -1,186 |
| Net Income | $-1,270 | $-1,272 | $-1,506 | $-12,584 | $-1,186 |
| EPS Basic Total Ops | -0.25 | -0.25 | -0.25 | -2.25 | -0.25 |
| EPS Basic Continuous Ops | -0.21 | -0.22 | -0.26 | -2.26 | -0.21 |
| EPS Diluted Total Ops | -0.25 | -0.25 | -0.25 | -2.25 | -0.25 |
| EPS Diluted Continuous Ops | -0.21 | -0.22 | -0.26 | -2.26 | -0.21 |
| EBITDA(a) | $-1,268 | $-1,338 | $-1,509 | $-3,368 | $-1,188 |